Caladrius Biosciences   Report issue

For profit Phase 2 Phase 3
Founded: Irvine CA United States (2005)

Organization Overview

First Clinical Trial
2005
NCT00012064
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Caladrius Biosciences, Inc. | Chief Medical Officer, Caladrius Biosciences | China Cell Technology Ltd | China Cell Technology Ltd. licensed CBMG to conduct the clinical trial as the sponsor in China | NeoStem Oncology, LLC